R&D / Scientists
| Title | Location | Job category | Date posted |
|---|---|---|---|
|
Oligonucleotide Design Lead (f/m/d)
Various Locations, AT, BE, DE, DK, ES, FR, GB, IE, IT, NL, PT
18 Nov 2026
|
|||
|
Global Regulatory Strategist (m/f/d)
Various Locations, AT, BE, DE, DK, ES, FR, GB, IE, IT, NL, PT
18 Nov 2026
|
Research & Development is dedicated to identifying, exploring and advancing innovative therapies for diseases with a high unmet medical need. At the heart of this is scientific excellence, cross-functional collaboration and a strong commitment to translate new therapeutic approaches into real-world impact.
A particular focus is on understanding the biological mechanisms behind pain and related diseases. Based on our industry-leading expertise in the pathophysiology of pain, sensory biology and neuronal health, Grünenthal develops new approaches to better understand disease mechanisms and address them with targeted therapies.
Keith Philips, Head of Genetic Medicine
Helps drive our RNA-based research programmes and develops our Genetic Medicine platform, exploring innovative scientific approaches and technologies that could lead to new treatment options and make a meaningful difference to patients.
Science Made Me...leveraging genetic medicine to help patients
Sevil Davidson, Computational Biologist
Leverages AI and machine learning to analyse complex scientific data, uncover meaningful insights and accelerate the identification of promising therapeutic candidates, supporting research into innovative treatment options for patients.
Science Made Me...develop algorithms that can design innovative molecules
Chanchal Kumar, Head, Bioinformatics, Disease Understanding
Fascinated by the opportunities of single-cell omics and the potential to turn vast amounts of data into knowledge that may deepen our understanding of pain and, ultimately, contribute to the creation of innovative treatment options.
Science Made Me...leveraging single-cell approaches in pain research
Maria Stupar, Global Safety Lead
Ensures that we maintain the highest safety standards for our products, using data-driven insights to support informed decisions and remain a trusted partner for healthcare professionals and the patients we serve.
Science Made Me...discover the power of data to ensure patient safety
Florian Jakob, Head of Drug Discovery Engine
Grown at Grünenthal from an early-career researcher into his current role. Excited by the idea of taking a tiny molecule and designing it to have a very specific, positive effect for patients, he pursues tomorrow’s innovations.
Science Made Me...seek big challenges with the potential to change patients' lives